Ref No: SportSG / SSI / FY16 / 44
13 Jan 2017
REVISIONS TO THE ANTI-DOPING SINGAPORE (ADS) THERAPEUTIC USE EXEMPTION (TUE) POLICY
The ADS TUE Policy has been revised to include changes to the 2017 Prohibited List. The key revisions to the ADS TUE Policy is to Section 4 (Procedure for Asthma Treated with Beta-2 Agonists) on the refinements and guidelines for the thresholds of permitted Beta-2 Agonists for treatment of asthma.
2 A copy of the revised ADS TUE policy with effect from 1 January 2017 is attached for your information. You may also download a copy of the TUE Policy from the ADS website at www.antidoping.org.sg.
3 We would like to take this opportunity to remind all athletes that the 2017 Prohibited List has taken effect on 1 January 2017 and to check the status of their medication prescribed or bought over-the-counter at pharmacies in Singapore by using the online database “CheckDrugs” which is accessible from Anti-Doping Singapore’s (ADS) website at www.antidoping.org.sg.
4 All carded athletes who need to be prescribed medication or methods of treatment that are prohibited should apply for a Therapeutic Use Exemption (TUE) to ADS before using it.
5 NSAs are kindly asked to convey the above updates and disseminate the revised ADS TUE Policy to all its athletes and officials.
6 Please do not hesitate to contact Ms Irene Tan at Tel: 65-65005451 or Email: irene_tan@sport.gov.sg if you need any clarification.
Thank you.
(Transmitted via Sport Singapore E-mail)
YEO Say Po (Ms)
General Manager
Anti-Doping Singapore | CEO Office Group
yeo_say_po@sport.gov.sg | T.65 6500 5056 | F. 65 6440 9205 | 3 Stadium Drive, Singapore 397630
CONFIDENTIALITY NOTICE: This email may contain privileged and confidential information. If you have been sent or have received this email by mistake, please notify the sender and delete the email immediately. You must not copy, use or disseminate the information contained in this email. Nothing in this email is intended to nor shall it constitute any offer or acceptance resulting in binding agreement, unless expressly stated otherwise.
|